Видео с ютуба (Hnscc)

The 1975 // HNSCC

The 1975 // HNSCC
The 1975 - HNSCC @ Alexandra Palace 01.10.14

The 1975 - HNSCC @ Alexandra Palace 01.10.14
FDA Approvals in HNSCC and DLBCL, and Encouraging Data in CLL, MDS, and CMML

FDA Approvals in HNSCC and DLBCL, and Encouraging Data in CLL, MDS, and CMML
CMP-001 for melanoma and HNSCC

CMP-001 for melanoma and HNSCC
TACTI 002 HNSCC SITC 2021 - Abstract # 359

TACTI 002 HNSCC SITC 2021 - Abstract # 359
HNSCC - The 1975 (Visualizer)

HNSCC - The 1975 (Visualizer)
ASPEN-04: evorpacept with pembrolizumab & chemotherapy in R/M HNSCC

ASPEN-04: evorpacept with pembrolizumab & chemotherapy in R/M HNSCC
The 1975 HNSCC - DC May 12

The 1975 HNSCC - DC May 12
Management of LA HNSCC, Moderated by Dr Kumar 04 09 2021

Management of LA HNSCC, Moderated by Dr Kumar 04 09 2021
The 1975 - HNSCC

The 1975 - HNSCC
Underlying Biology of HPV-Positive and -Negative HNSCC

Underlying Biology of HPV-Positive and -Negative HNSCC
HNSCC ricorrente/metastatico, l'update a 1 anno del trial TPExtreme

HNSCC ricorrente/metastatico, l'update a 1 anno del trial TPExtreme
Palliative treatment options and selection of the therapy for HNSCC by Dr. Surender Beniwal

Palliative treatment options and selection of the therapy for HNSCC by Dr. Surender Beniwal
surveillance in HNSCC

surveillance in HNSCC
Dr Kirtane on an Investigation of TILs Plus Pembrolizumab in Advanced HNSCC

Dr Kirtane on an Investigation of TILs Plus Pembrolizumab in Advanced HNSCC
Dr Sun on Tisotumab Vedotin in Recurrent or Metastatic HNSCC

Dr Sun on Tisotumab Vedotin in Recurrent or Metastatic HNSCC
Durvalumab plus danvatirsen for R/M HNSCC: exciting SCORES data

Durvalumab plus danvatirsen for R/M HNSCC: exciting SCORES data
Supraclean RunHD HNSCC NISSAN SKYLINE DRIFTING

Supraclean RunHD HNSCC NISSAN SKYLINE DRIFTING
Emerging PD-L1 Inhibitors for HNSCC

Emerging PD-L1 Inhibitors for HNSCC
Part 14 - Targeting EGFR in HNSCC - Dr. K. Govind Babu, Bengaluru

Part 14 - Targeting EGFR in HNSCC - Dr. K. Govind Babu, Bengaluru